Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome

Clinical Nephrology

Volumn 60, Issue 4, 2003, Pages 242-247

  Kemper, Markus J ^a   Meyer Jark, T ^a   Lilova, M ^a   Muller Wiefel D E ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

B cell activation; Immunoglobulins; Pathogenesis; Steroid sensitive nephrotic syndrome (SSNS); T cell activation

Indexed keywords

BIOLOGICAL MARKER; CREATININE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR; STEROID;

ADOLESCENT; ADULT; AGING; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; REMISSION; STATISTICAL ANALYSIS; T LYMPHOCYTE ACTIVATION; URINARY EXCRETION;

EID: 0141927144     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp60242     Document Type: Article

References (35)

1. Anonymous 1981 The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98: 561-564
2. Alsaran K, Grisaru S, Stephens D, Arbus G 2001 Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 56: 289-294
3. 3 and recombinant human erythropoietin treatment. Clin Nephrol 52: 230-238
4. Beale MG, Nash GS, Bertovich MJ, MacDermott RP 1983 Immunoglobulin synthesis by peripheral blood mononuclear cells in minimal change nephrotic syndrome. Kidney Int 23: 380-386
5. Bock GH, Ongkingco JR, Patterson LT, Raley J, Schroepfer LR, Nelson DL 1993 Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome. Pediatr Nephrol 7: 523-528
6. Bonnefoy JY, Lecoanet-Henchoz S, Gauchat JF, Graber P, Aubry JP, Jeannin P, Plater-Zyberk C 1997 Structure and functions of CD23. Int Rev Immunol 16: 113-128
7. Borel JF 1991 Mechanism of action of cyclosporin A and rationale for use in nephrotic syndrome. Clin Nephrol 35: S23-30
8. Brodehl J 1991 The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr 150: 380-387
9. Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE 1999 Upregulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 13: 199-204
10. Chung JB, Sater RA, Fields ML, Erikson J, Monroe JG 2002 CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int Immunol 14: 157-166
11. Clark A, Barrat T 1999 Steroid-responsive nephrotic syndrome. In: Barrat T, Avner E (eds) Pediatric Nephrology. Lippincot William and Wilkins, Baltimore, pp 731-748
12. Clark AG, Amlot P 1995 Ami-CD25 monoclonal antibody induces remission of steroid-responsive nephrotic syndrome - a case report. Pediatr Nephrol 9: C86
13. Daniel V, Trautmann Y, Konrad M, Nayir A, Schärer K 1997 T lymphocyte poulations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 47: 289-297
14. Descamps-Latscha B, Herbelin A, Nguyen AT, de Groote D, Chauveau P, Verger C, Jungers P, Zingraff J 1993 Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis. Kidney Int 43: 878-884
15. Di Lorenzo G, Drago A, Pellitteri ME, Candore G, Colombo A, Potestio M, Di Salvo A, Mansueto S, Caruso C 1999 Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season. Allergy Asthma Proc 20: 119-125
16. Ehrich JH, Brodehl J 1993 Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Pädiatrische Nephrologie. Eur J Pediatr 152: 357-361
17. Ewart MA, Ozanne BW, Cushle W 2002 The CD23a and CD23b proximal promotors display different sensitivities to exogenous stimuli in B lymphocytes. Genes Immun 3: 158-164
18. Giangiacomo J, Cleary TG, Cole BR, Hoffsten P, Robson AM 1975 Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome. N Engl J Med 293: 8-12
19. Hodson EM, Knight JF, Willis NS, Craig JC 2001 Corticosteroid therapy for nephrotic syndrome in children (Cochrane Review). Cochrane Database Syst Rev 2
20. Hulton SA, Neuhaus TJ, Callard RE, Dillon MJ, Barratt TM 1997 Circulating interleukin 2 receptor (IL2R) in nephrotic syndrome. Kidney Int Suppl 58: S83-84
21. Hulton SA, Shah V, Byrne MR, Morgan G, Barratt TM, Dillon MJ 1994 Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 8: 135-139
22. Kobayashi K, Yoshikawa N, Nakamura H 1994 T cell subpopulations in childhood nephrotic syndrome. Clin Nephrol 41: 253-258
23. Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME 2002 T lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39: 958-965
24. Mandreoli M, Beltrandi E, Casadei-Maldini M, Mancini R, Zucchelli A, Zucchelli P 1992 Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy. Clin Nephrol 37: 177-182
25. Meadow SR, Sarsfield JK, Scott DG, Rajah SM 1981 Steroid-responsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child 56: 517-524
26. Neuhaus TJ, Shah V, Callard RE, Barratt TM 1995 T lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood. Nephrol Dial Transplant 10: 1348-1352
27. Niaudet P, Habib R 1994 Cyclosporine in the treatment of idiopathic nephrosis [editorial]. J Am Soc Nephrol 5: 1049-1056
28. Rebien W, Müller-Wiefel DE, Wahn U, Schärer K 1981 IgE-mediated hypersensitivity in children with idiopathic nephrotic syndrome. Int J Pediatr Nephrol 2: 23-28
29. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P 2002 Rituximab for idiopathic membranous nephropathy. Lancet 360: 923-924
30. Schnaper HW 1989 The immune system in minimal change nephrotic syndrome. Pediatr Nephrol 3: 101-110
31. Shalhoub RJ 1974 Pathogenesis of lipoid nephrosis: a disorder of T cell function. Lancet 2: 556-560
32. Topaloglu R, Saatci U, Arikan M, Canpinar H, Bakkaloglu A, Kansu E 1994 T cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. Pediatr Nephrol 8: 649-652
33. Warshaw BL, Check IJ 1989 IgG subclasses in children with nephrotic syndrome. Am J Clin Pathol 92: 68-72
34. Yabuuchi S, Nakamura T, Kloetzer WS, Reff ME 2002 Anti-CD23 monoclonal antibody inhibits germline Cepsilon transcription in B cells. Int Immunopharmacol 2: 453-461
35. Yokoyama H, Kida H, Abe T, Koshino Y, Yoshimura M, Hattori N 1987 Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults. Clin Exp Immunol 70: 110-115